Home
Products
About Us
Blog
Contact Us
中文版
Company News
Industry News
An in-depth look at hydroxyapatite: an important recycled material
13 Feb,2025
In recent years, the field of regenerative materials has welcomed another heavyweight new star - HArmonyCa™ Mesotherapy Needle, which has been carefully developed by Allergan. This product has skillfully combined two powerful ingredients, Hyaluronic Acid (HA) and Calcium Hydroxyapatite (CaHA), and has injected new vitality into the medical aesthetic world.
Differences between hydroxyapatite (CaHA) and bone meal
Is hydroxyapatite (CaHA) bone meal? The answer is no, CaHA ≠ bone meal!
Unique features of the recycled material “Hydroxyapatite”.
Hydroxyapatite, a natural mineral carefully composed of hydroxyl groups and calcium phosphate, has shown its unique appeal in the field of medical aesthetics. Its molecular formula, Ca10(PO4)6(OH)2, is very similar to the mineral composition of bone, which allows it to achieve a close chemical bonding with human tissue.
Domestic new choice for future medical aesthetic filling: hydroxyapatite microspheres
28 Jul,2022
Calcium hydroxylapatite (CaHA) “Radiesse as an example” is a high temperature fired bioceramic whose main component is calcium hydroxylapatite microcrystalline spheres with a diameter of 25-45 micrometers.
3D printing + biomimicry to bring artificial bone to life in living organisms
10 Jan,2022
Bone defects are one of the most common diseases in orthopedic clinics. Every minute in China, there are 7 people with serious disabilities caused by traffic accidents, and there are about 10 million patients with bone defects every year.
Medical Beauty Leader, Officially Enters China's Orthopedic Treatment Market
12 Nov,2021
Recently, I was informed by the State Drug Administration that the allograft bone repair material “ExFuse”, which is suitable for “cooperating with non-degradable metal internal fixation products, used for filling the gap and crevice of bone defects of the limbs and spine under low weight-bearing condition during orthopedic surgery”, has been approved for registration by the State and officially launched on the market in China on November 26, 2019.